Investigating whether genetic knockdown of neuronal ACE1 impacts Aβ burden is important to not only understand the mechanism of neuronal ACE1 in AD pathogenesis, but also to examine the neurocognitive effect of ACE inhibitors as a treatment for hypertensive patients. This evidence concerns the gene ACE and Alzheimer disease.